Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 7 studies | 22% ± 5% | |
epithelial cell | 5 studies | 30% ± 8% | |
macrophage | 5 studies | 19% ± 4% | |
oligodendrocyte | 4 studies | 19% ± 3% | |
fibroblast | 3 studies | 19% ± 2% | |
dendritic cell | 3 studies | 19% ± 4% | |
glutamatergic neuron | 3 studies | 39% ± 17% | |
astrocyte | 3 studies | 29% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2137.21 | 1445 / 1445 | 100% | 22.19 | 183 / 183 |
ovary | 100% | 2205.22 | 180 / 180 | 100% | 13.88 | 430 / 430 |
prostate | 100% | 2060.64 | 245 / 245 | 100% | 18.85 | 502 / 502 |
stomach | 100% | 1556.54 | 359 / 359 | 100% | 18.27 | 286 / 286 |
uterus | 100% | 2119.85 | 170 / 170 | 100% | 18.10 | 459 / 459 |
breast | 100% | 2433.74 | 459 / 459 | 100% | 22.87 | 1117 / 1118 |
thymus | 100% | 2136.22 | 653 / 653 | 100% | 17.51 | 604 / 605 |
intestine | 100% | 2047.78 | 966 / 966 | 100% | 17.92 | 526 / 527 |
bladder | 100% | 2318.90 | 21 / 21 | 100% | 16.42 | 503 / 504 |
pancreas | 100% | 1229.30 | 327 / 328 | 100% | 16.58 | 178 / 178 |
lung | 100% | 1847.63 | 576 / 578 | 100% | 20.15 | 1155 / 1155 |
brain | 99% | 1660.97 | 2627 / 2642 | 100% | 19.82 | 705 / 705 |
liver | 100% | 1092.97 | 226 / 226 | 99% | 11.35 | 403 / 406 |
adrenal gland | 100% | 2271.17 | 258 / 258 | 99% | 13.20 | 228 / 230 |
kidney | 100% | 1702.38 | 89 / 89 | 99% | 15.36 | 893 / 901 |
skin | 100% | 3021.56 | 1809 / 1809 | 99% | 28.09 | 466 / 472 |
adipose | 100% | 2447.65 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2350.06 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 21.05 | 29 / 29 |
spleen | 100% | 1993.80 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 19.97 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.90 | 1 / 1 |
muscle | 100% | 1311.40 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 96% | 1202.37 | 829 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 24.88 | 77 / 80 |
peripheral blood | 84% | 1265.15 | 779 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000079 | Biological process | regulation of cyclin-dependent protein serine/threonine kinase activity |
GO_0006289 | Biological process | nucleotide-excision repair |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0006367 | Biological process | transcription initiation at RNA polymerase II promoter |
GO_0006281 | Biological process | DNA repair |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0009755 | Biological process | hormone-mediated signaling pathway |
GO_0006360 | Biological process | transcription by RNA polymerase I |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000439 | Cellular component | transcription factor TFIIH core complex |
GO_0005675 | Cellular component | transcription factor TFIIH holo complex |
GO_0046966 | Molecular function | nuclear thyroid hormone receptor binding |
GO_0005515 | Molecular function | protein binding |
GO_0003682 | Molecular function | chromatin binding |
Gene name | GTF2H1 |
Protein name | General transcription factor IIH subunit 1 General transcription factor IIH subunit 1 (Basic transcription factor 2 62 kDa subunit) (BTF2 p62) (General transcription factor IIH polypeptide 1) (TFIIH basal transcription factor complex p62 subunit) |
Synonyms | BTF2 |
Description | FUNCTION: Component of the general transcription and DNA repair factor IIH (TFIIH) core complex, which is involved in general and transcription-coupled nucleotide excision repair (NER) of damaged DNA and, when complexed to CAK, in RNA transcription by RNA polymerase II. In NER, TFIIH acts by opening DNA around the lesion to allow the excision of the damaged oligonucleotide and its replacement by a new DNA fragment. In transcription, TFIIH has an essential role in transcription initiation. When the pre-initiation complex (PIC) has been established, TFIIH is required for promoter opening and promoter escape. Phosphorylation of the C-terminal tail (CTD) of the largest subunit of RNA polymerase II by the kinase module CAK controls the initiation of transcription. . |
Accessions | ENST00000265963.9 [P32780-1] ENST00000453096.6 [P32780-1] ENST00000524753.4 ENST00000672845.1 [P32780-2] ENST00000672827.1 [P32780-1] F5H0Y9 ENST00000526630.2 ENST00000672527.1 [P32780-1] ENST00000525831.5 E9PM51 E9PI26 E9PL58 P32780 ENST00000534641.5 [P32780-2] ENST00000530496.6 |